{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:43:30Z","timestamp":1794642210912,"version":"4.9.1"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran","award":["RIGLD 1128"],"award-info":[{"award-number":["RIGLD 1128"]}],"id":[{"id":"https:\/\/ror.org\/034m2b326","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-024-03816-y","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T19:01:56Z","timestamp":1734894116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Global prevalence of Helicobacter pylori antibiotic resistance among children in the world health organization regions between 2000 and 2023: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Aryan","family":"Salahi-Niri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Nabavi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya Marie","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore","family":"Rokkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doulberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-7581","authenticated-orcid":false,"given":"Abbas","family":"Yadegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"2","key":"3816_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu JCY, et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 2017;153(2):420\u20139.","journal-title":"Gastroenterology"},{"issue":"3","key":"3816_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2352-4642(21)00400-4","volume":"6","author":"C Yuan","year":"2022","unstructured":"Yuan C, Adeloye D, Luk TT, Huang L, He Y, Xu Y, Ye X, Yi Q, Song P, Rudan I. The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022;6(3):185\u201394.","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"3816_CR3","first-page":"219","volume":"115","author":"M Narayanan","year":"2018","unstructured":"Narayanan M, Reddy KM, Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo Med. 2018;115(3):219\u201324.","journal-title":"Mo Med"},{"issue":"1","key":"3816_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2\u20139.","journal-title":"J Dig Dis"},{"key":"3816_CR5","doi-asserted-by":"crossref","unstructured":"\u0160amani\u0107 I, Dadi\u0107 B, Sanader Mar\u0161i\u0107 \u017d, D\u017eelalija M, Maravi\u0107 A, Kalini\u0107 H, Vrebalov Cindro P, \u0160undov \u017d, Tonki\u0107 M, Tonki\u0107 A et al: Molecular characterization and mutational analysis of clarithromycin- and levofloxacin-resistance genes in Helicobacter pylori from gastric biopsies in Southern Croatia. In: International Journal of Molecular Sciences. vol. 24; 2023.","DOI":"10.3390\/ijms241914560"},{"key":"3816_CR6","doi-asserted-by":"crossref","unstructured":"Yan L, Chen Y, Chen F, Tao T, Hu Z, Wang J, You J, Wong BCY, Chen J, Ye W: Effect of Helicobacter pylori eradication on gastric cancer prevention: updated report from a randomized controlled trial with 26.5 years of follow-up. Gastroenterology 2022, 163(1):154\u2013162.e153.","DOI":"10.1053\/j.gastro.2022.03.039"},{"key":"3816_CR7","doi-asserted-by":"crossref","unstructured":"Meli\u021b LE, M\u0103rginean CO, S\u0103s\u0103ran MO: The Challenges of eradicating pediatric Helicobacter pylori infection in the era of probiotics. Children (Basel) 2022, 9(6).","DOI":"10.3390\/children9060795"},{"key":"3816_CR8","unstructured":"Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994, 61:1\u2013241."},{"key":"3816_CR9","doi-asserted-by":"crossref","unstructured":"Homan M, Jones NL, Bontems P, Carroll MW, Czinn SJ, Gold BD, Goodman K, Harris PR, Jerris R, Kalach N et al: Updated joint ESPGHAN\/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr 2024.","DOI":"10.1002\/jpn3.12314"},{"issue":"1","key":"3816_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, Smith SI, Suerbaum S. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"3816_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3748\/wjg.v28.i7.766","volume":"28","author":"S Sitkin","year":"2022","unstructured":"Sitkin S, Lazebnik L, Avalueva E, Kononova S, Vakhitov T. Gastrointestinal microbiome and Helicobacter pylori: eradicate, leave it as it is, or take a personalized benefit-risk approach? World J Gastroenterol. 2022;28(7):766\u201374.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"3816_CR12","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","volume":"43","author":"I Thung","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514\u201333.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"3816_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.32641\/rchped.v91i5.2579","volume":"91","author":"PR Harris","year":"2020","unstructured":"Harris PR, Calder\u00f3n-Guerrero OG, Vera-Chamorro JF, Lucero Y, V\u00e1squez M, Kazuo Ogata S, Angulo D, Madrazo A, Gonz\u00e1les J, Rivero A, et al. Adaptation to the reality of Latin America of the NASPGHAN\/ESPGHAN 2016 Guidelines on the diagnosis, prevention and treatment of Helicobacter pylori infection in pediatrics. Rev Chil Pediatr. 2020;91(5):809\u201327.","journal-title":"Rev Chil Pediatr"},{"key":"3816_CR14","doi-asserted-by":"publisher","first-page":"175628482311700","DOI":"10.1177\/17562848231170052","volume":"16","author":"M Manfredi","year":"2023","unstructured":"Manfredi M, Gargano G, Gismondi P, Ferrari B, Iuliano S. Therapeutic eradication choices in Helicobacter pylori infection in children. Therap Adv Gastroenterol. 2023;16:17562848231170052.","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"3816_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.5223\/pghn.2019.22.5.417","volume":"22","author":"JS Jun","year":"2019","unstructured":"Jun JS, Seo JH, Park JS, Rhee KH, Youn HS. Changes in the treatment strategies for Helicobacter pylori Infection in children and adolescents in Korea. Pediatr Gastroenterol Hepatol Nutr. 2019;22(5):417\u201330.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"3816_CR16","unstructured":"World Health Organization regions [http:\/\/www.who.int\/about\/regions\/en.]"},{"issue":"9760","key":"3816_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0140-6736(10)60903-8","volume":"377","author":"A Booth","year":"2011","unstructured":"Booth A, Clarke M, Ghersi D, Moher D, Petticrew M, Stewart L. An international registry of systematic-review protocols. Lancet. 2011;377(9760):108\u20139.","journal-title":"Lancet"},{"key":"3816_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;350: g7647.","journal-title":"BMJ"},{"issue":"1","key":"3816_CR19","first-page":"60","volume":"32","author":"M Moubri","year":"2019","unstructured":"Moubri M, Kalach N, Larras R, Berrah H, Mouffok F, Guechi Z, Cadranel S. Adapted first-line treatment of Helicobacter pylori infection in Algerian children. Ann Gastroenterol. 2019;32(1):60\u20136.","journal-title":"Ann Gastroenterol"},{"issue":"12","key":"3816_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/00006454-200012000-00010","volume":"19","author":"V Tolia","year":"2000","unstructured":"Tolia V, Brown W, El-Baba M, Lin CH. Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J. 2000;19(12):1167\u201371.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"3816_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.gastro.2021.03.045","volume":"161","author":"KG Hulten","year":"2021","unstructured":"Hulten KG, Lamberth LB, Kalfus IN, Graham DY. National and regional US antibiotic resistance to Helicobacter pylori: lessons from a clinical trial. Gastroenterology. 2021;161(1):342-344.e341.","journal-title":"Gastroenterology"},{"issue":"6","key":"3816_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/MPG.0b013e31828b3669","volume":"56","author":"SK Ogata","year":"2013","unstructured":"Ogata SK, Godoy AP, da Silva Patricio FR, Kawakami E. High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents. J Pediatr Gastroenterol Nutr. 2013;56(6):645\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"3816_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.arcmed.2021.01.011","volume":"52","author":"P Gonz\u00e1lez-Hormaz\u00e1bal","year":"2021","unstructured":"Gonz\u00e1lez-Hormaz\u00e1bal P, Arenas A, Serrano C, Pizarro M, Fuentes-L\u00f3pez E, Arnold J, Berger Z, Musleh M, Valladares H, Lanzarini E, et al. Prevalence of Helicobacter pylori antimicrobial resistance among Chilean patients. Arch Med Res. 2021;52(5):529\u201334.","journal-title":"Arch Med Res"},{"issue":"4","key":"3816_CR24","first-page":"308","volume":"9","author":"F Siavoshi","year":"2006","unstructured":"Siavoshi F, Safari F, Doratotaj D, Khatami GR, Fallahi GH, Mirnaseri MM. Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children. Arch Iran Med. 2006;9(4):308\u201314.","journal-title":"Arch Iran Med"},{"issue":"2","key":"3816_CR25","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12098-007-0003-4","volume":"74","author":"GH Fallahi","year":"2007","unstructured":"Fallahi GH, Maleknejad S. Helicobacter pylori culture and antimicrobial resistance in Iran. Indian J Pediatr. 2007;74(2):127\u201330.","journal-title":"Indian J Pediatr"},{"issue":"5","key":"3816_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10156-007-0543-6","volume":"13","author":"M Rafeey","year":"2007","unstructured":"Rafeey M, Ghotaslou R, Nikvash S, Hafez AA. Primary resistance in Helicobacter pylori isolated in children from Iran. J Infect Chemother. 2007;13(5):291\u20135.","journal-title":"J Infect Chemother"},{"issue":"6","key":"3816_CR27","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s10156-012-0425-4","volume":"18","author":"M Milani","year":"2012","unstructured":"Milani M, Ghotaslou R, Akhi MT, Nahaei MR, Hasani A, Somi MH, Rafeey M, Sharifi Y. The status of antimicrobial resistance of Helicobacter pylori in Eastern Azerbaijan, Iran: comparative study according to demographics. J Infect Chemother. 2012;18(6):848\u201352.","journal-title":"J Infect Chemother"},{"issue":"6","key":"3816_CR28","doi-asserted-by":"publisher","DOI":"10.5812\/ijp.2661","volume":"25","author":"S Maleknejad","year":"2015","unstructured":"Maleknejad S, Mojtahedi A, Safaei-Asl A, Taghavi Z, Kazemnejad E. Primary antibiotic resistance to Helicobacter pylori strains isolated from children in Northern Iran: a single center study. Iran J Pediatr. 2015;25(6): e2661.","journal-title":"Iran J Pediatr"},{"key":"3816_CR29","first-page":"824","volume":"7","author":"A Massiha","year":"2017","unstructured":"Massiha A, Pahlaviani MRMK. A study on antimicrobial resistance of Helicobacter pylori Isolates recovered from dyspeptic patients by epsilometer test. International Journal of Molecular and Clinical Microbiology. 2017;7:824\u201333.","journal-title":"International Journal of Molecular and Clinical Microbiology"},{"key":"3816_CR30","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.2147\/IDR.S187885","volume":"11","author":"R Ranjbar","year":"2018","unstructured":"Ranjbar R, Chehelgerdi M. Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies. Infect Drug Resist. 2018;11:2545\u201354.","journal-title":"Infect Drug Resist"},{"key":"3816_CR31","doi-asserted-by":"crossref","unstructured":"Burayzat S, Al-Tamimi M, Barqawi M, Massadi MS, Abu-Raideh J, Albalawi H, Khasawneh AI, Himsawi N, Barber M: Antimicrobial resistance molecular mechanisms of Helicobacter pylori in Jordanian children: a cross-sectional observational study. Antibiotics (Basel) 2023, 12(3).","DOI":"10.3390\/antibiotics12030618"},{"issue":"3","key":"3816_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1523-5378.2010.00753.x","volume":"15","author":"A V\u00e9csei","year":"2010","unstructured":"V\u00e9csei A, Kipet A, Innerhofer A, Graf U, Binder C, Gizci H, Hammer K, Bruckdorfer A, Huber WD, Hirschl AM, et al. Time trends of Helicobacter pylori resistance to antibiotics in children living in Vienna. Austria Helicobacter. 2010;15(3):214\u201320.","journal-title":"Austria Helicobacter"},{"key":"3816_CR33","doi-asserted-by":"crossref","unstructured":"Kotilea K, Mekhael J, Salame A, Mahler T, Miendje-Deyi VY, Cadranel S, Bontems P: Eradication rate of Helicobacter pylori infection is directly influenced by adherence to therapy in children. Helicobacter 2017, 22(4).","DOI":"10.1111\/hel.12383"},{"key":"3816_CR34","doi-asserted-by":"crossref","unstructured":"Kotilea K, Iliadis E, Nguyen J, Salame A, Mahler T, Miendje Deyi VY, Bontems P: Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children. Helicobacter 2023:e13006.","DOI":"10.1111\/hel.13006"},{"issue":"Pt 9","key":"3816_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1099\/jmm.0.45651-0","volume":"53","author":"L Boyanova","year":"2004","unstructured":"Boyanova L, Gergova G, Koumanova R, Jelev C, Lazarova E, Mitov I, Kovacheva Y. Risk factors for primary Helicobacter pylori resistance in Bulgarian children. J Med Microbiol. 2004;53(Pt 9):911\u20134.","journal-title":"J Med Microbiol"},{"issue":"4","key":"3816_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.diagmicrobio.2007.11.008","volume":"60","author":"L Boyanova","year":"2008","unstructured":"Boyanova L, Gergova G, Nikolov R, Davidkov L, Kamburov V, Jelev C, Mitov I. Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods. Diagn Microbiol Infect Dis. 2008;60(4):409\u201315.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3816_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3109\/23744235.2015.1082035","volume":"48","author":"L Boyanova","year":"2016","unstructured":"Boyanova L, Gergova G, Evstatiev I, Spassova Z, Kandilarov N, Yaneva P, Markovska R, Mitov I. Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. Infect Dis (Lond). 2016;48(1):56\u201362.","journal-title":"Infect Dis (Lond)"},{"key":"3816_CR38","doi-asserted-by":"crossref","unstructured":"Boyanova L, Hadzhiyski P, Markovska R, Gergova R: Investigation of multidrug-resistant Helicobacter pylori in pediatric patients: a Bulgarian study and literature data. Acta Microbiol Immunol Hung 2022.","DOI":"10.1556\/030.2022.01682"},{"issue":"7","key":"3816_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1469-0691.2002.00435.x","volume":"8","author":"L Boyanova","year":"2002","unstructured":"Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, G\u00f6ral V, Kupcinskas L, Kantar\u00e7eken B, Aydin A, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect. 2002;8(7):388\u201396.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"3816_CR40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00431-012-1722-8","volume":"171","author":"I Hojsak","year":"2012","unstructured":"Hojsak I, Kos T, Duman\u010di\u0107 J, Mi\u0161ak Z, Jadre\u0161in O, Jaklin Kekez A, Luki\u0107 Grli\u0107 A, Kola\u010dek S. Antibiotic resistance of Helicobacter pylori in pediatric patients \u2013 10 years\u2019 experience. Eur J Pediatr. 2012;171(9):1325\u201330.","journal-title":"Eur J Pediatr"},{"key":"3816_CR41","doi-asserted-by":"crossref","unstructured":"Regnath T, Raecke O, Enninger A, Ignatius R: Increasing metronidazole and rifampicin resistance of Helicobacter pylori isolates obtained from children and adolescents between 2002 and 2015 in southwest Germany. Helicobacter 2017, 22(1).","DOI":"10.1111\/hel.12327"},{"key":"3816_CR42","doi-asserted-by":"crossref","unstructured":"Helmbold L, Ghebremedhin B, Bellm A, Hopkins MA, Wirth S, Aydin M: Increased antibiotic resistance in children with Helicobacter pylori infection: a retrospective study. Pathogens 2022, 11(2).","DOI":"10.3390\/pathogens11020178"},{"issue":"8","key":"3816_CR43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ja.2014.38","volume":"67","author":"A Peretz","year":"2014","unstructured":"Peretz A, Paritsky M, Nasser O, Brodsky D, Glyatman T, Segal S, On A. Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults. J Antibiot (Tokyo). 2014;67(8):555\u20137.","journal-title":"J Antibiot (Tokyo)"},{"issue":"12","key":"3816_CR44","first-page":"747","volume":"19","author":"M Kori","year":"2017","unstructured":"Kori M, Yahav J, Berdinstein R, Shmuely H. Primary and secondary antibiotic resistance of helicobacter pylori in israeli children and adolescents. Isr Med Assoc J. 2017;19(12):747\u201350.","journal-title":"Isr Med Assoc J"},{"key":"3816_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jgar.2017.05.017","volume":"10","author":"J Khoury","year":"2017","unstructured":"Khoury J, Geffen Y, Shaul R, Sholy H, Chowers Y, Saadi T. Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults. J Glob Antimicrob Resist. 2017;10:182\u20135.","journal-title":"J Glob Antimicrob Resist"},{"key":"3816_CR46","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jgar.2017.10.004","volume":"12","author":"N Pastukh","year":"2018","unstructured":"Pastukh N, Peretz A, Brodsky D, Isakovich N, Azrad M, On A. Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel. J Glob Antimicrob Resist. 2018;12:175\u20138.","journal-title":"J Glob Antimicrob Resist"},{"key":"3816_CR47","doi-asserted-by":"crossref","unstructured":"Manfredi M, Gismondi P, Maffini V, Bizzarri B, Fornaroli F, Madia C, Salerno A, Cangelosi AM. de\u2019Angelis GL: Primary antimicrobial susceptibility changes in children with Helicobacter pylori infection over 13 years in Northern Italy. Gastroenterol Res Pract. 2015;2015.","DOI":"10.1155\/2015\/717349"},{"issue":"1","key":"3816_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/apm.12752","volume":"126","author":"G Dargiene","year":"2018","unstructured":"Dargiene G, Kupcinskas J, Jonaitis L, Vezbavicius M, Kadusevicius E, Kupcinskiene E, Frandsen TH, Kucinskiene R, Kupcinskas L, Andersen LP. Primary antibiotic resistance of Helicobacter pylori strains among adults and children in a tertiary referral centre in Lithuania. APMIS. 2018;126(1):21\u20138.","journal-title":"APMIS"},{"issue":"3","key":"3816_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijantimicag.2005.06.015","volume":"26","author":"K Dzierzanowska-Fangrat","year":"2005","unstructured":"Dzierzanowska-Fangrat K, Rozynek E, Celi\u0144ska-Cedro D, Jarosz M, Paw\u0142owska J, Szadkowski A, Budzy\u0144ska A, Nowak J, Roma\u0144czuk W, Prosiecki R, et al. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents. 2005;26(3):230\u20134.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3816_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.33073\/pjm-2014-008","volume":"63","author":"G Go\u015bciniak","year":"2014","unstructured":"Go\u015bciniak G, Biernat M, Grabi\u0144ska J, Bi\u0144kowska A, Poniewierka E, Iwa\u0144czak B. The antimicrobial susceptibility of Helicobacter pylori strains isolated from children and adults with primary infection in the Lower Silesia Region. Poland Pol J Microbiol. 2014;63(1):57\u201361.","journal-title":"Poland Pol J Microbiol"},{"issue":"2","key":"3816_CR51","doi-asserted-by":"publisher","first-page":"263","DOI":"10.17219\/acem\/67716","volume":"26","author":"G Go\u015bciniak","year":"2017","unstructured":"Go\u015bciniak G, Biernat MM, Bi\u0144kowska A, Kus A, Iwa\u0144czak B. Frequency of infection with Helicobacter pylori isolates of different antimicrobial profiles in children and adolescents: a preliminary study. Adv Clin Exp Med. 2017;26(2):263\u20138.","journal-title":"Adv Clin Exp Med"},{"key":"3816_CR52","doi-asserted-by":"crossref","unstructured":"Krzy\u017cek P, Pawe\u0142ka D, Iwa\u0144czak B, Kempi\u0144ski R, Le\u015bniakowski K, M\u00e9graud F, \u0141aczma\u0144ski \u0141, Biernat M, Go\u015bciniak G: High primary antibiotic resistance of Helicobacter pylori strains isolated from pediatric and adult patients in Poland during 2016\u20132018. Antibiotics (Basel) 2020, 9(5).","DOI":"10.3390\/antibiotics9050228"},{"key":"3816_CR53","doi-asserted-by":"crossref","unstructured":"Biernat MM, Bi\u0144kowska A, \u0141aczma\u0144ski \u0141, Biernat P, Krzy\u017cek P, Go\u015bciniak G: Phenotypic and genotypic analysis of resistant Helicobacter pylori strains isolated from children with gastrointestinal diseases. Diagnostics (Basel) 2020, 10(10).","DOI":"10.3390\/diagnostics10100759"},{"issue":"5","key":"3816_CR54","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/01.inf.0000160941.65324.6b","volume":"24","author":"AI Lopes","year":"2005","unstructured":"Lopes AI, Oleastro M, Palha A, Fernandes A, Monteiro L. Antibiotic-resistant Helicobacter pylori strains in Portuguese children. Pediatr Infect Dis J. 2005;24(5):404\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"3816_CR55","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1093\/jac\/dkr293","volume":"66","author":"M Oleastro","year":"2011","unstructured":"Oleastro M, Cabral J, Ramalho PM, Lemos PS, Paix\u00e3o E, Benoliel J, Santos A, Lopes AI. Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period. J Antimicrob Chemother. 2011;66(10):2308\u201311.","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3816_CR56","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12528","volume":"23","author":"GM Silva","year":"2018","unstructured":"Silva GM, Silva HM, Nascimento J, Gon\u00e7alves JP, Pereira F, Lima R. Helicobacter pylori antimicrobial resistance in a pediatric population. Helicobacter. 2018;23(5): e12528.","journal-title":"Helicobacter"},{"key":"3816_CR57","doi-asserted-by":"crossref","unstructured":"Butenko T, Jeverica S, Orel R, Homan M: Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children. Helicobacter 2017, 22(5).","DOI":"10.1111\/hel.12400"},{"issue":"2","key":"3816_CR58","first-page":"88","volume":"22","author":"S Agudo","year":"2009","unstructured":"Agudo S, Alarc\u00f3n T, Cibrelus L, Urruzuno P, Mart\u00ednez MJ, L\u00f3pez-Brea M. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children. Rev Esp Quimioter. 2009;22(2):88\u201392.","journal-title":"Rev Esp Quimioter"},{"key":"3816_CR59","doi-asserted-by":"crossref","unstructured":"Montes M, Villalon FN, Eizaguirre FJ, Delgado M, Mu\u00f1oz-Seca IM, Fern\u00e1ndez-Reyes M, P\u00e9rez-Trallero E: Helicobacter pylori infection in children. antimicrobial resistance and treatment response. Helicobacter 2015, 20(3):169\u2013175.","DOI":"10.1111\/hel.12187"},{"issue":"6","key":"3816_CR60","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.anpedi.2020.10.006","volume":"95","author":"G Botija","year":"2021","unstructured":"Botija G, Garc\u00eda Rodr\u00edguez C, Recio Linares A, Campelo Guti\u00e9rrez C, P\u00e9rez-Fern\u00e1ndez E, Barrio Merino A. Antibiotic resistances and eradication rates in Helicobacter pylori infection. An Pediatr (Engl Ed). 2021;95(6):431\u20137.","journal-title":"An Pediatr (Engl Ed)"},{"issue":"5","key":"3816_CR61","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/MPG.0000000000000273","volume":"58","author":"H Karabiber","year":"2014","unstructured":"Karabiber H, Selimoglu MA, Otlu B, Yildirim O, Ozer A. Virulence factors and antibiotic resistance in children with Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr. 2014;58(5):608\u201312.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"3816_CR62","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1523-5378.2011.00856.x","volume":"16","author":"G Liu","year":"2011","unstructured":"Liu G, Xu X, He L, Ding Z, Gu Y, Zhang J, Zhou L. Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children. Helicobacter. 2011;16(5):356\u201362.","journal-title":"Helicobacter"},{"key":"3816_CR63","doi-asserted-by":"crossref","unstructured":"Li L, Ke Y, Yu C, Li G, Yang N, Zhang J, Li Y: Antibiotic resistance of Helicobacter pylori in Chinese children: a multicenter retrospective study over 7\u00a0years. Helicobacter 2017, 22(3).","DOI":"10.1111\/hel.12373"},{"issue":"3","key":"3816_CR64","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12481","volume":"23","author":"X Shu","year":"2018","unstructured":"Shu X, Yin G, Liu M, Peng K, Zhao H, Jiang M. Antibiotics resistance of Helicobacter pylori in children with upper gastrointestinal symptoms in Hangzhou, China. Helicobacter. 2018;23(3): e12481.","journal-title":"Helicobacter"},{"key":"3816_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2147\/IDR.S235615","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wen Y, Xiao Q, Zheng W, Long G, Chen B, Shu X, Jiang M. Mutations in the antibiotic target genes related to clarithromycin, metronidazole and levofloxacin resistance in Helicobacter pylori strains from children in China. Infect Drug Resist. 2020;13:311\u201322.","journal-title":"Infect Drug Resist"},{"key":"3816_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.621791","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Deng J, Wang Z, Li H, Wan C. Antibiotic resistance of Helicobacter pylori strains isolated from pediatric patients in Southwest China. Front Microbiol. 2020;11: 621791.","journal-title":"Front Microbiol"},{"issue":"12","key":"3816_CR67","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.5152\/tjg.2021.20791","volume":"32","author":"L Wang","year":"2021","unstructured":"Wang L, Zhang J, Hu M, Pang X. Comparison of drug resistance of Helicobacter pylori between children and adults in Jilin. China Turk J Gastroenterol. 2021;32(12):1012\u20138.","journal-title":"China Turk J Gastroenterol"},{"issue":"1","key":"3816_CR68","doi-asserted-by":"publisher","first-page":"17754","DOI":"10.1038\/s41598-022-21661-y","volume":"12","author":"X Shu","year":"2022","unstructured":"Shu X, Ye D, Hu C, Peng K, Zhao H, Li H, Jiang M. Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years. Sci Rep. 2022;12(1):17754.","journal-title":"Sci Rep"},{"issue":"7","key":"3816_CR69","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s00431-022-04456-1","volume":"181","author":"T Geng","year":"2022","unstructured":"Geng T, Yu ZS, Zhou XX, Liu B, Zhang HH, Li ZY. Antibiotic resistance of Helicobacter pylori isolated from children in Chongqing. China Eur J Pediatr. 2022;181(7):2715\u201322.","journal-title":"China Eur J Pediatr"},{"issue":"2","key":"3816_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1128\/JCM.40.2.649-653.2002","volume":"40","author":"S Kato","year":"2002","unstructured":"Kato S, Fujimura S, Udagawa H, Shimizu T, Maisawa S, Ozawa K, Iinuma K. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol. 2002;40(2):649\u201353.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"3816_CR71","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1442-200X.2009.02915.x","volume":"52","author":"S Kato","year":"2010","unstructured":"Kato S, Fujimura S. Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years. Pediatr Int. 2010;52(2):187\u201390.","journal-title":"Pediatr Int"},{"issue":"12","key":"3816_CR72","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/ped.14388","volume":"62","author":"S Kato","year":"2020","unstructured":"Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, Fujimura S, Kamiya S, Konno M, Kuwabara K, et al. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int. 2020;62(12):1315\u201331.","journal-title":"Pediatr Int"},{"issue":"1","key":"3816_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12868","volume":"27","author":"JG Huang","year":"2022","unstructured":"Huang JG, Lim SYS, Aw MM, Quak SH. Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort. Helicobacter. 2022;27(1): e12868.","journal-title":"Helicobacter"},{"issue":"7","key":"3816_CR74","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00006454-200107000-00005","volume":"20","author":"YJ Yang","year":"2001","unstructured":"Yang YJ, Yang JC, Jeng YM, Chang MH, Ni YH. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. Pediatr Infect Dis J. 2001;20(7):662\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"3816_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12633","volume":"24","author":"HH Lu","year":"2019","unstructured":"Lu HH, Lai FP, Lo HY, Sheu BS, Yang YJ. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: a comparison between two decades. Helicobacter. 2019;24(5): e12633.","journal-title":"Helicobacter"},{"key":"3816_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.916848","volume":"13","author":"CH Lai","year":"2022","unstructured":"Lai CH, Lin TL, Huang MZ, Li SW, Wu HY, Chiu YF, Yang CY, Chiu CH, Lai HC. Gut commensal Parabacteroides goldsteinii MTS01 alters gut microbiota composition and reduces cholesterol to mitigate Helicobacter pylori-induced pathogenesis. Front Immunol. 2022;13: 916848.","journal-title":"Front Immunol"},{"issue":"4","key":"3816_CR77","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1523-5378.2012.00950.x","volume":"17","author":"TV Nguyen","year":"2012","unstructured":"Nguyen TV, Bengtsson C, Yin L, Nguyen GK, Hoang TT, Phung DC, S\u00f6rberg M, Granstr\u00f6m M. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. Helicobacter. 2012;17(4):319\u201325.","journal-title":"Helicobacter"},{"issue":"2","key":"3816_CR78","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5455\/medarh.2021.75.112-115","volume":"75","author":"H Van Thieu","year":"2021","unstructured":"Van Thieu H, Duc NM, Nghi BTD, Van Bach N, Khoi HH, Tien VNT, Bang MTL, Ngoc TLC. Antimicrobial resistance and the successful eradication of Helicobacter pylori-induced gastroduodenal ulcers in Vietnamese children. Med Arch. 2021;75(2):112\u20135.","journal-title":"Med Arch"},{"key":"3816_CR79","doi-asserted-by":"crossref","unstructured":"Le LTT, Nguyen TA, Nguyen NA, Nguyen YTH, Nguyen HTB, Nguyen LT, Vi MT, Nguyen T: Antibiotic resistance of Helicobacter pylori in children with gastritis and peptic ulcers in Mekong Delta, Vietnam. Healthcare (Basel) 2022a, 10(6).","DOI":"10.3390\/healthcare10061121"},{"key":"3816_CR80","doi-asserted-by":"crossref","unstructured":"Le LTT, Nguyen TA, Nguyen NA, Nguyen YTH, Nguyen HTB, Nguyen LT, Vi MT, Nguyen T: Helicobacter pylori eradication efficacy of therapy based on the antimicrobial susceptibility in children with gastritis and peptic ulcer in Mekong Delta, Vietnam. Children (Basel) 2022b, 9(7).","DOI":"10.3390\/children9071019"},{"key":"3816_CR81","doi-asserted-by":"crossref","unstructured":"Nguyen TC, Le GKN, Pham DTH, Pham BV, Nguyen LTH, Che TH, Nguyen HT, Truong DQ, Robert A, Bontems P et al: Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: a prospective multicenter study. Helicobacter 2023:e13009.","DOI":"10.1111\/hel.13009"},{"issue":"1","key":"3816_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016;151(1):51-69.e14.","journal-title":"Gastroenterology"},{"issue":"1","key":"3816_CR83","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, et al. Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report. Gut. 2017;66(1):6\u201330.","journal-title":"Gut"},{"key":"3816_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"issue":"3","key":"3816_CR85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","volume":"3","author":"Z Munn","year":"2014","unstructured":"Munn Z, Moola S, Riitano D, Lisy K. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 2014;3(3):123\u20138.","journal-title":"Int J Health Policy Manag"},{"issue":"29","key":"3816_CR86","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen T, Hamza TH, Ozdemir P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat Med. 2010;29(29):3046\u201367.","journal-title":"Stat Med"},{"issue":"25","key":"3816_CR87","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1002\/sim.7411","volume":"36","author":"D Jackson","year":"2017","unstructured":"Jackson D, Law M, R\u00fccker G, Schwarzer G. The Hartung-Knapp modification for random-effects meta-analysis: a useful refinement but are there any residual concerns? Stat Med. 2017;36(25):3923\u201334.","journal-title":"Stat Med"},{"issue":"11","key":"3816_CR88","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"2","key":"3816_CR89","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112\u201325.","journal-title":"Res Synth Methods"},{"issue":"7109","key":"3816_CR90","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"key":"3816_CR91","doi-asserted-by":"crossref","unstructured":"Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E: Emerging treatment options for multi-drug-resistant bacterial infections. Life (Basel) 2021, 11(6).","DOI":"10.3390\/life11060519"},{"key":"3816_CR92","doi-asserted-by":"crossref","unstructured":"Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Mitic Culafic D, Trudic A, Ranin L, Opavski N: Antimicrobial susceptibility testing: a comprehensive review of currently used methods. Antibiotics (Basel) 2022, 11(4).","DOI":"10.3390\/antibiotics11040427"},{"issue":"1","key":"3816_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13104-019-4877-9","volume":"13","author":"M Miftahussurur","year":"2020","unstructured":"Miftahussurur M, Fauzia KA, Nusi IA, Setiawan PB, Syam AF, Waskito LA, Doohan D, Ratnasari N, Khomsan A, Adnyana IK, et al. E-test versus agar dilution for antibiotic susceptibility testing of Helicobacter pylori: a comparison study. BMC Res Notes. 2020;13(1):22.","journal-title":"BMC Res Notes"},{"key":"3816_CR94","doi-asserted-by":"crossref","unstructured":"Alfaray RI, Saruuljavkhlan B, Fauzia KA, Torres RC, Thorell K, Dewi SR, Kryukov KA, Matsumoto T, Akada J, Vilaichone RK et al: Global antimicrobial resistance gene study of Helicobacter pylori: comparison of detection tools, ARG and efflux pump gene analysis, worldwide epidemiological distribution, and information related to the antimicrobial-resistant phenotype. Antibiotics (Basel) 2023, 12(7).","DOI":"10.3390\/antibiotics12071118"},{"key":"3816_CR95","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2147\/IDR.S192942","volume":"12","author":"SJ Hashemi","year":"2019","unstructured":"Hashemi SJ, Sheikh AF, Goodarzi H, Yadyad MJ, Seyedian SS, Aslani S, Assarzadegan MA. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect Drug Resist. 2019;12:535\u201343.","journal-title":"Infect Drug Resist"},{"key":"3816_CR96","doi-asserted-by":"publisher","first-page":"1435064","DOI":"10.3389\/fcell.2024.1435064","volume":"12","author":"J Huang","year":"2024","unstructured":"Huang J, Li Z, Ge F, Sun C, Deng Z, Yao W, He X. Functional determination of site-mutations in rdxA involved in metronidazole resistance of Helicobacter pylori. Front Cell Dev Biol. 2024;12:1435064.","journal-title":"Front Cell Dev Biol"},{"key":"3816_CR97","doi-asserted-by":"crossref","unstructured":"Argueta EA, Ho JJC, Elfanagely Y, D'Agata E, Moss SF: Clinical implication of drug resistance for H. pylori management. Antibiotics (Basel) 2022, 11(12).","DOI":"10.3390\/antibiotics11121684"},{"issue":"5","key":"3816_CR98","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health organization Regions. Gastroenterology. 2018;155(5):1372-1382.e1317.","journal-title":"Gastroenterology"},{"issue":"12","key":"3816_CR99","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1136\/gut.2006.091272","volume":"55","author":"S Koletzko","year":"2006","unstructured":"Koletzko S, Richy F, Bontems P, Crone J, Kalach N, Monteiro ML, Gottrand F, Celinska-Cedro D, Roma-Giannikou E, Orderda G, et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut. 2006;55(12):1711\u20136.","journal-title":"Gut"},{"key":"3816_CR100","doi-asserted-by":"crossref","unstructured":"Borka Balas R, Meli\u021b LE, M\u0103rginean CO: Current worldwide trends in pediatric Helicobacter pylori antimicrobial resistance. Children (Basel) 2023, 10(2).","DOI":"10.3390\/children10020403"},{"issue":"1","key":"3816_CR101","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2019.04.011","volume":"157","author":"CA Fallone","year":"2019","unstructured":"Fallone CA, Moss SF, Malfertheiner P. Reconciliation of recent Helicobacter pylori treatment guidelines in a time of increasing resistance to antibiotics. Gastroenterology. 2019;157(1):44\u201353.","journal-title":"Gastroenterology"},{"issue":"2","key":"3816_CR102","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","volume":"57","author":"P Katelaris","year":"2023","unstructured":"Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, M\u00e9graud F, Piscoya A, Quach D, et al. Helicobacter pylori World Gastroenterology Organization Global Guideline. J Clin Gastroenterol. 2023;57(2):111\u201326.","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"3816_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-017-8535-7","volume":"102","author":"K Goderska","year":"2018","unstructured":"Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018;102(1):1\u20137.","journal-title":"Appl Microbiol Biotechnol"},{"key":"3816_CR104","doi-asserted-by":"crossref","unstructured":"Malik SS, Mundra S: Increasing consumption of antibiotics during the COVID-19 pandemic: implications for patient health and emerging anti-microbial resistance. Antibiotics (Basel) 2022, 12(1).","DOI":"10.3390\/antibiotics12010045"},{"issue":"6","key":"3816_CR105","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/pathogens12060780","volume":"12","author":"V Petrakis","year":"2023","unstructured":"Petrakis V, Panopoulou M, Rafailidis P, Lemonakis N, Lazaridis G, Terzi I, Papazoglou D, Panagopoulos P. The impact of the COVID-19 pandemic on antimicrobial resistance and management of bloodstream infections. Pathogens. 2023;12(6):780.","journal-title":"Pathogens"},{"key":"3816_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.590683","volume":"11","author":"S Rezasoltani","year":"2020","unstructured":"Rezasoltani S, Yadegar A, Hatami B, Asadzadeh Aghdaei H, Zali MR. Antimicrobial resistance as a hidden menace lurking behind the COVID-19 outbreak: the global impacts of too much hygiene on AMR. Front Microbiol. 2020;11: 590683.","journal-title":"Front Microbiol"},{"key":"3816_CR107","doi-asserted-by":"crossref","unstructured":"Fair RJ, Tor Y: Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 2014, 6:25-64.","DOI":"10.4137\/PMC.S14459"},{"key":"3816_CR108","doi-asserted-by":"crossref","unstructured":"M\u00e9graud F, Graham DY, Howden CW, Trevino E, Weissfeld A, Hunt B, Smith N, Leifke E, Chey WD. Rates of antimicrobial resistance in Helicobacter pylori isolates from clinical trial patients across the US and Europe. Am J Gastroenterol. 2023;118(2):269\u201375.","DOI":"10.14309\/ajg.0000000000002045"},{"key":"3816_CR109","doi-asserted-by":"crossref","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O'Morain C et al: Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut 2022.","DOI":"10.1136\/gutjnl-2022-327745"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03816-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03816-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T20:02:57Z","timestamp":1734897777000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03816-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3816"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03816-y","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable; this manuscript does not include any details, images, or videos relating to an individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}